Ostarine (Ostarol, GTx-024, MK-2866): A Popular Selective Androgen Receptor Modulator (SARM)
Ostarine is a selective androgen receptor modulator developed by Merck & Company and GTx Incorporated for the treatment of conditions like osteoporosis and muscular dystrophy. Although it has only recently appeared on the domestic market, its popularity is growing rapidly.
In the USA, SARMs have gained significant traction among athletes, with many incorporating Ostarine into their training and nutrition regimens, especially when preparing for competitions.
Effectiveness and Usage
Ostarine’s effectiveness is supported by its widespread use among world-class athletes. Notably, an athlete who achieved the best result of the season at the World Long Jump Championship was suspended due to Ostarine use, underscoring the drug’s powerful performance-enhancing effects.
There are no reviews yet.